The Molecular Research on Incretins and Diabetic Comorbidities

Dear Colleagues,

Diabetes increases the risk of various comorbidities, such as coronary artery disease, peripheral artery disease, retinopathy, neuropathy, nephropathy, and stroke in patients with diabetes. Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) could ameliorate hyperglycemia and prevent the related comorbidities in patients with diabetes. However, the molecular mechanisms of GIP or GLP-1 on the diabetic comorbidities remain to be elucidated.

For this Special Issue, we invite original research and review articles on recent progress in molecular mechanisms of incretins and diabetic complications in animals or humans, in vitro culture experiments, and in vivo models to investigate the potential of incretins to the comorbidities in diabetes.

Dr. Michishige Terasaki
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• GIP
• GLP-1
• differentiation
• atherosclerosis
• intestine
• animal models
• drug screening